Reshma, R., Jeankumar, V., Kapoor, N., Saxena, S., Bobesh, K., Vachaspathy, A., … Sriram, D. (2017). Mycobacterium tuberculosis lysine-ɛ-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors. Bioorganic & Medicinal Chemistry, 25(10), 2761-2771. https://doi.org/10.1016/j.bmc.2017.03.053 (Original work published 2017)

Reshma, R., Saxena, S., Bobesh, K., Jeankumar, V., Gunda, S., Yogeeswari, P., & Sriram, D. (2016). Design and development of new class of Mycobacterium tuberculosisl-alanine dehydrogenase inhibitors. Bioorganic & Medicinal Chemistry, 24(18), 4499-4508. https://doi.org/10.1016/j.bmc.2016.07.051 (Original work published 2016)

Jeankumar, V., Reshma, R., Vats, R., Janupally, R., Saxena, S., Yogeeswari, P., & Sriram, D. (2016). Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors. European Journal of Medicinal Chemistry, 122, 216-231. https://doi.org/10.1016/j.ejmech.2016.06.042 (Original work published 2016)

Jeankumar, V., Saxena, S., Vats, R., Reshma, R., Janupally, R., Kulkarni, P., … Sriram, D. (2016). Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain. ChemMedChem, 11(5), 539-48. https://doi.org/10.1002/cmdc.201500556 (Original work published 2016)

Devi, P., Sridevi, J., Kakan, S., Saxena, S., Jeankumar, V., , … Sriram, D. (2015). Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis. Tuberculosis (Edinburgh, Scotland), 95(6), 786-794. https://doi.org/10.1016/j.tube.2015.04.010

Jeankumar, V., Reshma, R., Janupally, R., Saxena, S., Sridevi, J., Medapi, B., … Sriram, D. (2015). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry, 13(8), 2423-31. https://doi.org/10.1039/c4ob02049a (Original work published 2015)

Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)

Saxena, S., Renuka, J., Jeankumar, V., Yogeeswari, P., & Sriram, D. Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. Current Topics in Medicinal Chemistry, 14(17), 1990-2005. Retrieved from http://www.eurekaselect.com/124977/article (Original work published 2014)

Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)

Jeankumar, V., Renuka, J., Kotagiri, S., Saxena, S., Kakan, S., Sridevi, J., … Sriram, D. (2014). Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues. ChemMedChem, 9(8), 1850-9. https://doi.org/10.1002/cmdc.201402035